A pilot study to evaluate the effect of HAART on gonadal dysfunction in male HIV patients
Abhishek Pathak, Lalit Prashant Meena, Jaya Chakravarty, Madhukar Rai, Shyam Sundar.
|Cited by (1)|
Background: Derangement of gonadal functions has been reported in association with HIV infection, but data from Indian population are not sufficient.
Aims & Objective: To evaluate the effect of highly active antiretroviral therapy (HAART) on the gonadal dysfunction in male HIV patients.
Materials and Methods: A total of 45 male HIV-positive patients were included and divided in two groups on the basis of CD4 cell count. Patients in groups A and B had CD4 count ≤200 and >200 cell/μL, respectively. Baseline hormone level was measured before the start of HAART, and the patients were followed up for 6 months and the hormone levels were measured again.
Results: In group A (n = 29), six (20.69%) patients had testosterone level
Key words: Highly Active Antiretroviral Therapy (HAART); Human Immunodeficiency Virus (HIV); Endocrine Changes